Skip to main content
InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
0.850
-0.030 (-3.41%)
At close: Feb 27, 2026, 4:00 PM EST
0.884
+0.034 (4.04%)
After-hours: Feb 27, 2026, 5:30 PM EST

InMed Pharmaceuticals Revenue

InMed Pharmaceuticals had revenue of $820.19K in the quarter ending December 31, 2025, a decrease of -26.22%. This brings the company's revenue in the last twelve months to $4.51M, down -6.73% year-over-year. In the fiscal year ending June 30, 2025, InMed Pharmaceuticals had annual revenue of $4.94M with 7.50% growth.

Revenue (ttm)
$4.51M
Revenue Growth
-6.73%
P/S Ratio
0.77
Revenue / Employee
$346,661
Employees
13
Market Cap
3.46M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20254.94M344.90K7.50%
Jun 30, 20244.60M462.17K11.18%
Jun 30, 20234.14M3.05M279.61%
Jun 30, 20221.09M--
Jun 30, 2021---
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
IM Cannabis 37.61M
Sunshine Biopharma 37.32M
Universe Pharmaceuticals INC 17.86M
Sonoma Pharmaceuticals 17.72M
RedHill Biopharma 9.55M
China Pharma Holdings 4.05M
China SXT Pharmaceuticals 1.54M
Akanda 836.66K
Revenue Rankings

INM News

More News